All Stories

  1. Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function

    Article • International Journal of Cardiology, November 2018, Elsevier

    Jonathan Salcedo

  2. A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma

    Article • Journal of Asthma, August 2018, Taylor & Francis

    Jonathan Salcedo